We are live on ! Find out more
TCPG

Trivant Custom Portfolio Group Portfolio holdings

AUM $182M
1-Year Est. Return 19.54%
This Fund
S&P 500
This Quarter Est. Return
+4.91%
1 Year Est. Return
+19.54%
3 Year Est. Return
+68.37%
5 Year Est. Return
10 Year Est. Return
AUM
$163M
AUM Growth
+$5.65M
Cap. Flow
+$229K
Cap. Flow %
0.14%
Top 10 Hldgs %
41.5%
Holding
199
New
16
Increased
34
Reduced
53
Closed
12

Top Buys

Rank Stock Value
1
MSCI icon
MSCI
MSCI
+$1.59M
2
AZO icon
AutoZone
AZO
+$1.38M
3
ZTS icon
Zoetis
ZTS
+$1.07M
4
UBS icon
UBS Group
UBS
+$985K
5
LLY icon
Eli Lilly
LLY
+$834K

Top Sells

Rank Stock Value
1
SRE icon
Sempra
SRE
+$1.85M
2
AZN icon
AstraZeneca
AZN
+$1.15M
3
CRM icon
Salesforce
CRM
+$1.1M
4
KIM icon
Kimco Realty
KIM
+$1.03M
5
BHP icon
BHP
BHP
+$973K

Sector Composition

Rank Sector Weight
1 Technology 26.95%
2 Healthcare 11.53%
3 Industrials 11.15%
4 Consumer Discretionary 10.27%
5 Financials 7.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CVX icon
26
Chevron
CVX
$388B
$2.53M 1.56%
16,188
+255
+2% +$40.7K
STZ icon
27
Constellation Brands
STZ
$22.2B
$2.52M 1.55%
9,800
-23
-0.2% -$5.92K
ABT icon
28
Abbott
ABT
$180B
$2.51M 1.54%
24,142
-316
-1% -$33.5K
TMO icon
29
Thermo Fisher Scientific
TMO
$211B
$2.42M 1.49%
4,379
-87
-2% -$49.8K
OTIS icon
30
Otis Worldwide
OTIS
$27.4B
$2.21M 1.36%
22,917
-126
-0.5% -$12.1K
HSY icon
31
Hershey
HSY
$35.4B
$1.65M 1.01%
8,956
+398
+5% +$77K
PHM icon
32
Pultegroup
PHM
$24.5B
$1.64M 1.01%
14,918
+1,472
+11% +$167K
LNG icon
33
Cheniere Energy
LNG
$56.5B
$1.64M 1.01%
9,367
-18
-0.2% -$2.87K
ROK icon
34
Rockwell Automation
ROK
$51.4B
$1.58M 0.97%
5,746
+257
+5% +$69.4K
CRM icon
35
Salesforce
CRM
$134B
$1.57M 0.97%
6,118
-4,129
-40% -$1.1M
MSCI icon
36
MSCI
MSCI
$40B
$1.54M 0.95%
+3,205
New +$1.59M
BHP icon
37
BHP
BHP
$213B
$1.52M 0.94%
26,683
-16,749
-39% -$973K
AZO icon
38
AutoZone
AZO
$48.3B
$1.4M 0.86%
+473
New +$1.38M
SRE icon
39
Sempra
SRE
$60.8B
$1.27M 0.78%
16,730
-25,062
-60% -$1.85M
ULTA icon
40
Ulta Beauty
ULTA
$20.4B
$1.16M 0.71%
3,015
-2,081
-41% -$846K
ZTS icon
41
Zoetis
ZTS
$31.6B
$1.13M 0.7%
6,547
+6,451
+6,720% +$1.07M
SPY icon
42
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$1.05M 0.64%
1,925
+65
+3% +$34K
QQQ icon
43
Invesco QQQ Trust
QQQ
$455B
$980K 0.6%
2,046
+41
+2% +$18.4K
UBS icon
44
UBS Group
UBS
$170B
$979K 0.6%
+33,150
New +$985K
LLY icon
45
Eli Lilly
LLY
$1.07T
$944K 0.58%
+1,043
New +$834K
KIM icon
46
Kimco Realty
KIM
$17.6B
$732K 0.45%
37,637
-55,132
-59% -$1.03M
INTU icon
47
Intuit
INTU
$81.1B
$726K 0.45%
1,105
-20
-2% -$12.4K
VOO icon
48
Vanguard S&P 500 ETF
VOO
$968B
$724K 0.44%
1,447
+10
+0.7% +$4.81K
EVR icon
49
Evercore
EVR
$13.1B
$694K 0.43%
+3,331
New +$648K
SNY icon
50
Sanofi
SNY
$104B
$587K 0.36%
12,106
-16,353
-57% -$789K

Similar funds

Trivant Custom Portfolio Group's Q2 2024 Portfolio in Review

As of Q2 2024, Trivant Custom Portfolio Group held 199 positions worth $163M, up 3.6% from $157M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Trivant Custom Portfolio Group's Q2 2024 filing shows 16 new, 34 increased, 53 reduced and 12 closed positions. Its largest new stake was MSCI: 3,205 shares worth $1.54M. The largest sale was Sempra, an estimated $1.85M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Healthcare and Industrials.

  • Trivant Custom Portfolio Group's largest Q2 2024 buy was MSCI: 3,205 shares worth $1.54M.
  • Trivant Custom Portfolio Group added most to Zoetis in Q2 2024, an estimated $1.07M increase.
  • Trivant Custom Portfolio Group's biggest Q2 2024 reduction was Sempra, cutting an estimated $1.85M.
  • Trivant Custom Portfolio Group fully exited AstraZeneca in Q2 2024, selling an estimated $1.15M.
  • Trivant Custom Portfolio Group's ten largest holdings make up 41% of its $163M portfolio in Q2 2024.
  • Trivant Custom Portfolio Group opened 16 new positions and closed 12 in Q2 2024.
  • Trivant Custom Portfolio Group's portfolio value rose 3.6% quarter-over-quarter to $163M.

Based on Trivant Custom Portfolio Group's 13F filing for Q2 2024, filed 17 Jul 2024.